Cellebrite DI (CLBT) Receivables (2020 - 2026)

Cellebrite DI has reported Receivables for 7 years, with the latest figure at $370.4 million in Q2 2026.

• On a quarterly basis, Receivables rose 7.4% year-over-year to $370.4 million in Q2 2026; TTM through Jun 2026 was $370.4 million, a 7.4% increase from a year earlier, with the FY2025 full-year figure at $405.7 million, up 18.08% from the prior year.
• Receivables was $370.4 million for Q2 2026 at Cellebrite DI, up from $137.4 million in the prior quarter.
• The five-year high for Receivables was $370.4 million in Q2 2026, with the low at $64.5 million in Q3 2022.
• Average Receivables over 5 years is $159.4 million, with a median of $98.4 million recorded in 2024.
• The largest YoY upside for Receivables was 105.81% in 2024 against a maximum downside of 18.71% in 2024.
• Over 5 years, Receivables stood at $65.9 million in 2022, then rose by 20.74% to $79.5 million in 2023, then surged by 105.81% to $163.7 million in 2024, then rose by 12.12% to $183.5 million in 2025, then jumped by 101.83% to $370.4 million in 2026.
• The last three Receivables figures came in at $370.4 million (Q2 2026), $137.4 million (Q1 2026), and $183.5 million (Q4 2025), per Business Quant data.